About PDA Letter

The PDA Letter is PDA's membership publication covering the science, technology, quality, regulatory affairs and association news and updates relevant to the PDA community. It publishes 10 times per year, with issues in January, February, March, April, May, June, September and October, as well as two larger issues for July/August and November/December.

The PDA Letter is divided into seven sections, one for each PDA department and a features section. Feature articles are supplied by PDA members, industry and regulatory experts and occasionally by PDA staff. The PDA Letter Editorial Committee (PLEC) provides editorial oversight for all feature articles. 

PDA Letter Editorial Committee

  • Ross Acucena, EMD Millipore
  • Suzanne Auckerman, Auckerman Consulting
  • Jennifer Bibeault, MassBiologics
  • Jose Caraballo, Bayer
  • Robert Darius, GlaxoSmithKline
  • Mike DeFelippis, PhD, Eli Lilly
  • Robert Dream, HDR COMPANY
  • Tricia Griffiths, Pall Life Sciences
  • Maik Jornitz, G-Con
  • Peter NoveriniAzbil BioVigilant
  • Leticia Quinones, PhD, Bristol-Myers Squibb 
  • Debbie Rogers, Ben Venue Laboratories
  • Siegfried Schmitt, PhD, PAREXEL
  • Barbara Sneade, Grifols
  • Sherry TamuraBiogen Idec
  • Elisa Yee, Hospira

PDA Letter Staff

Walter Morris, Director of Publishing
Tel: (301) 656-5900 x148
E-mail: morris@pda.org

Rebecca Stauffer, Editor/Writer
Tel: (301) 656-5900 x120
E-mail: stauffer@pda.org

Katja Yount, Publication Design Specialist
Tel: (301) 656-5900 x161
E-mail: yount@pda.org